Anzeige
Meldung des Tages: Early Bird Special: Ad-hoc im Schatten einer milliardenschweren Entscheidung

Ginkgo Bioworks News

Aktie
WKN:  A40KL9 ISIN:  US37611X2099 US-Symbol:  DNA Branche:  Biotechnologie Land:  USA
9,70 $
+1,24 $
+14,66%
8,2758 € 01.05.26
Depot/Watchlist
Marktkapitalisierung *
346,22 Mio. €
Streubesitz
25,08%
KGV
-1,44
Index-Zuordnung
-

Ginkgo Bioworks News

30.04.26 - PR Newswire
Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation
Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation PR Newswire
02.03.26 - PR Newswire
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure PR Newswire
26.02.26 - PR Newswire
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity ...
19.02.26 - PR Newswire
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation PR Newswire
18.02.26 - PR Newswire
Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products
Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-​based Agricultural Products PR Newswire
05.02.26 - PR Newswire
Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark
Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-​of-the-Art Scientific Benchmark PR Newswire
13.01.26 - PR Newswire
Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference PR Newswire
22.12.25 - PR Newswire
Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach
Ginkgo Bioworks Partners with Carnegie-​Mellon University to Develop Innovative New Cancer Screening Approach PR Newswire
17.12.25 - PR Newswire
Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment
Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment PR Newswire
09.12.25 - PR Newswire
Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety
Ginkgo Bioworks partners on Deep Origin-​led team to develop new tools for predicting drug safety PR Newswire
05.12.25 - PR Newswire
Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC
Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC PR Newswire
03.12.25 - PR Newswire
STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy
STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-​Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy PR Newswire
18.11.25 - PR Newswire
Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health
Ginkgo Bioworks Partners on Illinois-​Led Team to Develop Innovative New Treatments for Oral Health PR Newswire
06.11.25 - PR Newswire
Ginkgo Bioworks Reports Third Quarter 2025 Financial Results
Ginkgo Bioworks Reports Third Quarter 2025 Financial Results PR Newswire
03.11.25 - PR Newswire
Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium
Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-​Consortium PR Newswire
31.10.25 - PR Newswire
Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture
Ginkgo Bioworks and Bayer Extend Multi-​Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture PR Newswire
30.10.25 - PR Newswire
Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation
Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation PR Newswire
23.10.25 - PR Newswire
Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program
Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program PR Newswire
29.08.25 - PR Newswire
Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions
Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions PR Newswire
20.08.25 - PR Newswire
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-​in-the-loop Workflows Across the Biopharma Industry PR Newswire

Newssuche

Videos

newspaper
26.04.26
Big Fish Strategy Einführung
Strategie-​Paket inklusive Live-​Webinar am 3.5., Videoaufzeichnung, Unterlagen und Nachbetreuung JETZT ... Mehr »
Anzeige

Aktie im Fokus

Mit Graphen gegen jede Abwehr
Plaid Technologies
0,396 €
+7,03%
Plaid Technologies Chart
Die Zukunft der Drohnen ist da
Mehr zur Aktie »